Hemodynamic benefits of matrix metalloproteinase-9 inhibition by doxycycline during experimental acute pulmonary embolism (2005)
- Authors:
- USP affiliated authors: GERLACH, RAQUEL FERNANDA - FORP ; SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidades: FORP; FMRP
- Assunto: EMBOLIA
- Language: Inglês
- Imprenta:
- Source:
-
ABNT
PALEI, Ana C. T. et al. Hemodynamic benefits of matrix metalloproteinase-9 inhibition by doxycycline during experimental acute pulmonary embolism. Angiology, v. 56, n. 5, p. 611-617, 2005Tradução . . Acesso em: 27 dez. 2025. -
APA
Palei, A. C. T., Zaneti, R. A. G., Fortuna, G. M., Gerlach, R. F., & Tanus-Santos, J. E. (2005). Hemodynamic benefits of matrix metalloproteinase-9 inhibition by doxycycline during experimental acute pulmonary embolism. Angiology, 56( 5), 611-617. -
NLM
Palei ACT, Zaneti RAG, Fortuna GM, Gerlach RF, Tanus-Santos JE. Hemodynamic benefits of matrix metalloproteinase-9 inhibition by doxycycline during experimental acute pulmonary embolism. Angiology. 2005 ; 56( 5): 611-617.[citado 2025 dez. 27 ] -
Vancouver
Palei ACT, Zaneti RAG, Fortuna GM, Gerlach RF, Tanus-Santos JE. Hemodynamic benefits of matrix metalloproteinase-9 inhibition by doxycycline during experimental acute pulmonary embolism. Angiology. 2005 ; 56( 5): 611-617.[citado 2025 dez. 27 ] - A role for matrix metalloproteinase-9 in the hemodynamic changes following acute pulmonary embolism
- Determinação de gelatinases no fluido gengival em pacientes sadios e com doença periodontal
- Comparative study on antioxidant effects and vascular matrix metalloproteinase-2 downregulation by dihydropyridines in renovascular hypertension
- Metalloproteinase inhibition protects against cardiomyocyte injury during experimental acute pulmonary thromboembolism
- Chronic treatment with nebivolol attenuates the vascular changes in the 2-kidney, 1-clip model of renovascular hypertension
- Nitric oxide attenuates matrix metalloproteinase-9 production by endothelial cells
- Atorvastatin and sildenafil lower blood pressure and improve endothelial dysfunction, but only atorvastatin increases vascular stores of nitric oxide in hypertension
- Atorvastatin and sildenafil decrease vascular TGF-β levels and MMP-2 activity and ameliorate arterial remodeling in a model of renovascular hypertension
- Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome
- Inibição de metaloproteinases (MMPs) com Doxycycline atenua a embolia pulmonar aguda (EPA)-indutor de hipotensão sistêmica
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
